-
1.发明申请Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1) 失效针对血小板因子-4变体1（PF4V1）的中和抗体及其片段公开(公告)号：US20110250210A1
公开(公告)日：2011-10-13
申请号：US13122468
申请日：2009-10-07
IPC分类号： A61K39/395 , C07H21/00 , C12N15/63 , C12N5/10 , C12N1/00 , C12P21/00 , G01N33/566 , A61P35/00 , A61P27/02 , A61P7/02 , A61P7/00 , A61P9/10 , A61P9/12 , A61P3/10 , A61P9/00 , A61P29/00 , C07K16/24
CPC分类号： C07K16/24 , A61K49/0032 , A61K49/0058 , C07K2317/74 , C07K2317/76 , C07K2319/23
摘要： The present invention relates to neutralizing antibodies and fragments thereof directed against Platelet Factor-4 variant 1 (PF4v1) and their use for treating pathologies that require induction of angiogenesis or diseases associated with pathological angiogenesis.
摘要翻译： 本发明涉及针对血小板因子-4变体1（PF4v1）的中和抗体及其片段及其用于治疗需要诱导血管发生或与病理血管发生相关的疾病的病理学的用途。
-
2.发明授权Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1) 失效针对血小板因子-4变体1（PF4V1）的中和抗体及其片段公开(公告)号：US08481033B2
公开(公告)日：2013-07-09
申请号：US13122468
申请日：2009-10-07
IPC分类号： A61K39/00
CPC分类号： C07K16/24 , A61K49/0032 , A61K49/0058 , C07K2317/74 , C07K2317/76 , C07K2319/23
摘要： The present invention relates to neutralizing antibodies and fragments thereof directed against Platelet Factor-4 variant 1 (PF4v1) and their use for treating pathologies that require induction of angiogenesis or diseases associated with pathological angiogenesis.
摘要翻译： 本发明涉及针对血小板因子-4变体1（PF4v1）的中和抗体及其片段及其用于治疗需要诱导血管发生或与病理血管发生相关的疾病的病理学的用途。
-
搜索结果
2 条记录 (耗时 0.016 秒)
